Global Neurology Academy

The Future of MS Management: Novel Agents and Clinical Approaches
The Future of MS Management: Novel Agents and Clinical Approaches
NeuroFrontiers
The Future of MS Management: Novel Agents and Clinical Approaches
- Marisa McGinley, DO
MS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern
MS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern
NeuroFrontiers
MS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
NeuroFrontiers
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
Reevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
Reevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
NeuroFrontiers
Reevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
NeuroFrontiers
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
- David Gate, PhD
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiers
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiers
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
Reevaluating Spinal Muscular Atrophy Therapy: Signs, Tools, and Strategies
Reevaluating Spinal Muscular Atrophy Therapy: Signs, Tools, and Strategies
NeuroFrontiers
Reevaluating Spinal Muscular Atrophy Therapy: Signs, Tools, and Strategies
- Brian P. McDonough, MD, FAAFP
- Nancy Kuntz, MD

Medical News

Medical News
Advancing Alzheimer's Management: NMDA Blockers and Early Detection Strategies
08/28/2025
Read more
Medical News
Advancements in Cognitive Therapy and Brain Health: Bridging Mental Health and Neuroplasticity
08/28/2025
Read more
Medical News
Nutritional Deficiencies and Autism: A Focus on Vitamin D and Iron
08/27/2025
Read more
Medical News
Purposeful Living and Alzheimer's: Lifestyle Interventions for Cognitive Health
08/27/2025
Read more

See more news

CME/CE

The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
CME/CE
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
1.00 credit
- Alejandro A. Rabinstein, MD, FAHA
- Richard E. Pratley, MD
- Jay H. Shubrook, DO, FACOFP, FAAFP
1.00 credit
New Frontiers in the Treatment of DMD Across the Age Spectrum
New Frontiers in the Treatment of DMD Across the Age Spectrum
CME/CE
New Frontiers in the Treatment of DMD Across the Age Spectrum
1.00 credit
- Crystal Proud, MD
- John Brandsema, MD
- Omer Abdul Hamid, MD
1.00 credit
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
MinuteCE®
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
MinuteCE®
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
1.00 credit 10 episodes
- Vera Bril, MD
- Nicholas J. Silvestri, MD
- Hans Katzberg, MD
1.00 credit 10 episodes

Clinical Practice

Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
NeuroFrontiers
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
NeuroFrontiers
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
- Marisa McGinley, DO
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
NeuroFrontiers
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
- Marisa McGinley, DO
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiers
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context

Programs

Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
NeuroFrontiers
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
NeuroFrontiers
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
Global Neurology Academy
Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
- Ashley Baker, MSN, PMHNP
- Stephanie Nahas, MD, MSEd
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
Global Neurology Academy
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
- Ryan Quigley
- Lyn R. Griffiths